IP Verse

Regeneron Pharmaceuticals, Inc. et al. v. Novartis Pharma AG et al. - IPR2021-00816

Explore the PTAB proceeding IPR2021-00816 filed by Regeneron Pharmaceuticals, Inc. et al. against Novartis Pharma AG et al. on Apr 16, 2021. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number
IPR2021-00816
Filing Date
Apr 16, 2021
Petitioner
Regeneron Pharmaceuticals, Inc. et al.
Respondent
Novartis Pharma AG et al.
Status
Final Written Decision
Respondent Application Number
13750352
Respondent Tech Center
3700
Respondent Patent Number
9220631
Institution Decision Date
Oct 26, 2021
Termination Date
Oct 25, 2022

Decision Documents New

Decision pending - set alert to receive updates

Counsels Involved New

Details of counsels involved in proceeding number IPR2021-00816.

TypeName
Petitioner CounselDesai, Anishet al
Respondent CounselHolland, Elizabethet al

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.